SCHEMBL18859540

SCHEMBL18859540

c1ccc2c(c1)sc1c(-c3ccc(-c4nc5c6ccccc6sc5c5ccccc45)cc3)cccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.52
▸ TNKS O95271 2/20 0.40
▸ TNKS2 Q9H2K2 2/20 0.40
▸ PARP14 Q460N5 1/20 0.40
▸ PRKDC P78527 4/20 0.39
▸ LIMK1 P53667 3/20 0.38
▸ CDK5 Q00535 1/20 0.37
▸ CDK5R1 Q15078 1/20 0.37
▸ PIK3CD O00329 1/20 0.37
▸ PIK3CB P42338 1/20 0.37
▸ MAPT P10636 1/20 0.36
▸ GPR3 P46089 1/20 0.36
▸ PIM1 P11309 1/20 0.35
▸ PIM2 Q9P1W9 1/20 0.35
▸ KRAS P01116 1/20 0.35
▸ HRH4 Q9H3N8 1/20 0.34
▸ ADK P55263 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C8 P10632 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22274171 0.92 ALOX5 (0.46) ALOX5TNKSTNKS2PARP14PRKDC
SCHEMBL18806050 0.89 ALOX5 (0.53) ALOX5TNKSTNKS2PARP14PRKDC
SCHEMBL24280710 0.87 ALOX5 (0.43) ALOX5TNKSTNKS2PARP14PRKDC
SCHEMBL24280548 0.87 ALOX5 (0.49) ALOX5TNKSTNKS2PARP14PRKDC
SCHEMBL24280858 0.86 ALOX5 (0.42) ALOX5TNKSTNKS2PARP14PRKDC
SCHEMBL24280663 0.85 ALOX5 (0.41) ALOX5TNKSTNKS2PARP14PRKDC
SCHEMBL18859782 0.85 TNKS (0.43) TNKSTNKS2LIMK1CDK5CDK5R1
SCHEMBL12268357 0.84 ALOX5 (0.51) ALOX5TNKSTNKS2PARP14PRKDC
SCHEMBL24280422 0.84 ALOX5 (0.46) ALOX5TNKSTNKS2PARP14PRKDC
SCHEMBL24280424 0.84 ALOX5 (0.44) ALOX5TNKSTNKS2PARP14PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10644244-B2 Heterocyclic compound and organic light emitting device using same LT MATERIALS CO., LTD. (KR) 2020-05-05 — — US disclosed
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-18 — — US disclosed
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME CRY1, CRY2, CYBA ALOX5 1302/4885TNKS 1638/4885TNKS2 1814/4885
US-10644244-B2 Heterocyclic compound and organic light emitting device using same CRY1, CRY2, CYBA ALOX5 1302/4885TNKS 1638/4885TNKS2 1814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback